Novartis data at ASCO and EHA reinforce company’s commitment to reimagining cancer
Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of...
Astellas Appoints Bernhardt Zeiher, M.D., as New Chief Medical Officer
Astellas is pleased to announce that Bernhardt G. Zeiher, M.D., F.C.C.P., F.A.C.P., ("Bernie"), was promoted to Chief Medical Officer (CMO),...
HDA’s Pharmaceutical Cargo Security Coalition Recognizes Leaders for Commitment to a Safe and Secure Supply Chain
HDA’s Pharmaceutical Cargo Security Coalition (PCSC) presented three awards at its educational seminar in East Hanover, New Jersey. Presented annually,...
PAREXEL Co-Founder and Board Chairman Josef von Rickenbach Receives 2018 Ellis Island Medal of Honor
PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, announced that Josef von Rickenbach, PAREXEL co-founder and Chairman of...
Novartis ARROW trial to assess mechanistic superiority of direct IL-17A inhibition (Cosentyx®) over IL-23 inhibition
Novartis announced the plan to initiate ARROW, a head-to-head proof of concept study to assess the mechanistic superiority of the...
Boehringer Ingelheim inaugurates its new integrated Asian Veterinary Research & Development Centre
Boehringer Ingelheim, the world’s second largest animal health company, has been boosting its investment in China by expanding the Asian...
DSM invests to increase global Dyneema® production capacity
Royal DSM, a global science-based company active in health, nutrition, materials, announced to increase its production capacity for Dyneema®, the...
Sumitomo Dainippon Pharma Announces Joint Research Agreement with MMVÂ for Identification of Antimalarial Candidate Compounds
Sumitomo Dainippon Pharma Co., Ltd. announced that it has signed an agreement with Medicines for Malaria Venture (Geneva, Switzerland; "MMV") on...
Baxter Reports First-Quarter 2018 Results and Increases Financial Outlook for Full-Year 2018
Baxter International Inc. reported results for the first quarter of 2018 and increased its full-year 2018 guidance. “Baxter is off...
Alexion Reports First Quarter 2018 Results And Positive Topline Data From ALXN1210 Phase 3 PNH Switch Study
Alexion Pharmaceuticals, Inc. announced financial results for the first quarter of 2018. Total revenues in the first quarter were $930.9...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.